Related Experiment Video
Updated: Jul 12, 2026

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase
Published on: June 30, 2023
Pasireotide induces proteins related to autophagy in cancer cells
Madan Sigdel1, Saikat Fakir1, Md Matiur Rahman Sarker1
1School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA, 71201, USA.
Purpose:
To investigate the possibility that Pasireotide (PAS), which is a synthetic somatostatin analog (SSA), induces proteins related to autophagy in cancer cells.
Methods:
MDA-MB-468 and HeLa human cancer cells were exposed to PAS or vehicle for 8, 24 and 32 h, to assess possible effects in autophagy-related proteins. Western blot analysis was utilized to assess changes in protein expression levels due to PAS exposure.
Results:
PAS treatment induces the expression of the autophagy-related protein (ATG)-3, ATG-7, and Beclin-1 in MDA-MB-468 and HeLa cells.
Conclusions:
Our findings suggest that the beneficial effects of PAS in cancers may involve autophagy. Further studies will attempt to elucidate the underlying mechanisms mediating those effects.
Insights
Pasireotide (PAS), a synthetic somatostatin analog, was found to increase autophagy-related proteins in cancer cells. These findings suggest PAS may exert beneficial effects in cancer by modulating autophagy.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Autophagy is a cellular process involved in maintaining homeostasis.
- Dysregulation of autophagy is implicated in various cancers.
- Synthetic somatostatin analogs (SSAs) are used in cancer therapy.
Purpose of the Study:
- To investigate if Pasireotide (PAS), an SSA, influences autophagy-related proteins in cancer cells.
- To explore the potential role of autophagy in the anti-cancer effects of PAS.
Main Methods:
- Human cancer cell lines (MDA-MB-468 and HeLa) were treated with PAS or a vehicle control.
- Cells were analyzed at different time points (8, 24, and 32 hours).
- Western blot analysis was used to quantify changes in autophagy-related protein expression.
Main Results:
- PAS treatment significantly increased the expression of autophagy-related proteins ATG-3, ATG-7, and Beclin-1.
- These effects were observed in both MDA-MB-468 and HeLa cancer cell lines.
- The induction of these proteins suggests PAS impacts the autophagic pathway.
Conclusions:
- The study indicates that Pasireotide (PAS) can induce autophagy-related proteins in cancer cells.
- Autophagy modulation may be a key mechanism underlying the anti-cancer effects of PAS.
- Further research is warranted to fully elucidate the mechanisms involved.
More Related Videos
09:59Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy
Published on: May 3, 2013
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
PI3K/mTOR/AKT Signaling Pathway
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
The Intrinsic Apoptotic Pathway